A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Polyomavirus specific T cells ViraCyte (Primary)
- Indications Human polyomavirus infections
- Focus Adverse reactions
- Acronyms VIRALYM-B
- Sponsors ViraCyte
- 01 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 01 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2019.
- 01 Nov 2017 Planned initiation date changed from 1 Jan 2017 to 1 Jan 2018.